ROLE OF FOCAL ADHESION KINASE IN LUNG REMODELING OF ENDOTOXEMIC RATS

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
SHOCK, v.37, n.5, p.524-530, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Despite significant advances in the care of critically ill patients, acute lung injury continues to be a complex problem with high mortality. The present study was designed to characterize early lipopolysaccharide (LPS)-induced pulmonary injury and small interfering RNA targeting focal adhesion kinase (FAK) as a possible therapeutic tool in the septic lung remodeling process. Male Wistar rats were assigned into endotoxemic group and control group. Total collagen deposition was performed 8, 16, and 24 h after LPS injection. Focal adhesion kinase expression, interstitial and vascular collagen deposition, and pulmonary mechanics were analyzed at 24 h. Intravenous injection of small interfering RNA targeting FAK was used to silence expression of the kinase in pulmonary tissue. Focal adhesion kinase, total collagen deposition, and pulmonary mechanics showed increased in LPS group. Types I, III, and V collagen showed increase in pulmonary parenchyma, but only type V increased in vessels 24 h after LPS injection. Focal adhesion kinase silencing prevented lung remodeling in pulmonary parenchyma at 24 h. In conclusion, LPS induced a precocious and important lung remodeling. There was fibrotic response in the lung characterized by increased amount in total and specific-type collagen. These data may explain the frequent clinical presentation during sepsis of reduced lung compliance, oxygen diffusion, and pulmonary hypertension. The fact that FAK silencing was protective against lung collagen deposition underscores the therapeutic potential of FAK targeting by small interfering RNA.
Palavras-chave
Sepsis, lung, remodeling, collagen type I, collagen type III, V, FAK
Referências
  1. AHRENDT GM, 1994, ARCH SURG-CHICAGO, V129, P1179
  2. Budinger GRS, 2005, INTENS CARE MED, V31, P121, DOI 10.1007/s00134-004-2503-2
  3. Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a
  4. Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978
  5. Dal-Pizzol F, 2006, AM J RESP CRIT CARE, V173, P84, DOI 10.1164/rccm.200507-1118OC
  6. de Souza AB, 2003, J PNEUMOL, V29, P235
  7. Eble DM, 2000, AM J PHYSIOL-HEART C, V278, pH1695
  8. Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1183/09031936.00.15108500
  9. Franchini KG, 2009, BRAZ J MED BIOL RES, V42, P44
  10. Garippo A, 2007, CLINICS, V62, P499
  11. Guido MC, 2012, SHOCK, V37, P77, DOI 10.1097/SHK.0b013e31823532ec
  12. Marshall R, 1998, THORAX, V53, P815
  13. Martin GS, 2005, CRIT CARE, V9, pR74, DOI 10.1186/cc3025
  14. Melo ES, IMMUNOBIOLOGY, V215, P435
  15. Melo ES, 1993, MOL IMMUNOL, V47, P2587
  16. Menezes SLS, 2005, J APPL PHYSIOL, V98, P1777, DOI 10.1152/japplphysiol.01182.2004
  17. Mian MF, 2008, CHEM-BIOL INTERACT, V171, P57, DOI 10.1016/j.cbi.2007.08.009
  18. Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011
  19. Parra ER, 2006, J HISTOCHEM CYTOCHEM, V54, P1315, DOI 10.1369/jhc.6A6969.2006
  20. Pelosi P, 2007, AN ACAD BRAS CIENC, V79, P285
  21. Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004
  22. Santos CC, 2008, INTENS CARE MED, V34, P619
  23. Schwulst JS, 2008, SHOCK, V30, P127
  24. Shimabukuro DW, 2003, CRIT CARE MED, V31, pS524, DOI 10.1097/01.CCM.0000081437.06466.B3
  25. Soriano FG, 2006, CRIT CARE MED, V34, P1073, DOI 10.1097/01.CCM.0000206470.47721.8D
  26. Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008
  27. Steinberg KP, 2006, NEW ENGL J MED, V354, P1671
  28. Taylor JM, 2000, J BIOL CHEM, V275, P19250, DOI 10.1074/jbc.M909099199
  29. Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B
  30. Tsuchida S, 2005, AM J PHYSIOL-LUNG C, V289, pL554, DOI 10.1152/ajplung.00143.2005
  31. UHLIG S, 1995, AM J PATHOL, V146, P1235
  32. Velosa APP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-1
  33. Vincent JL, 2002, CLIN INFECT DIS, V34, P1084, DOI 10.1086/339549
  34. Wei W, 2010, SHOCK, V33, P218, DOI 10.1097/SHK.0b013e3181aef736
  35. Zeisel MB, 2005, J IMMUNOL, V174, P7393